Nimes

France

87 total trials 38 recruiting

Filter these 87 trials by phase, condition, sponsor and more.

Open in Search →

Loc-R01: Randomized Phase IB/II Study of escalating doses of Lenalidomide and Ibrutinib in association with R-MPV as a targeted induction tr … Ended recruitment

2024-515331-30-00 7 2020-10-30 Primary Central Nervous System Lymphoma (PCNSL)
A Phase 3 Study Comparing Lenalidomide and Daratumumab Subcutaneous Injection (R-Dara SC) vs Lenalidomide and Dexamethasone (Rd) in Frail Su … Ended recruitment

2024-514088-25-00 5 2019-10-07 Multiple Myeloma
study of the efficacy of treatment with AG-221 in patients with myelodysplastic syndrome and mutation IDH2 Ended recruitment

2024-513858-29-01 4 2019-02-06 myelodysplastic syndrome with IDH2 mutated
Randomized trial of avelumab-cetuximab-Radiotherapy versus standards of care in the head and neck cancers Ended recruitment

2024-513964-24-00 5 2017-09-14 Squamous cell carcinoma, previously untreated Stage III, stage IVa (op
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Crohn's Disease who Comple … Ended recruitment

2023-504951-29-00 5 2017-07-27 Chron's Disease
Use of electronic cigarettes for smoking cessation Halted

2024-518135-10-00 5 2024-10-31 Smokers smoking at least 10 cigarettes/day in the past year
A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib … Halted

2024-516672-16-00 5 2024-02-02 Multiple Sclerosis
Effect of psilocybin on the positive valence system in treatment-resistant depression: a pilot clinical neuroimaging study Ended

2022-501092-11-00 4 2024-11-05 depression
AMX0035 and Progressive Supranuclear Palsy Ended

2023-505893-14-00 5 2024-06-04 Progressive Supranuclear Palsy
Psilocybin in alcohol use disorder with comorbid depression - Randomized double-blind controlled pilot study. Ended

2023-506647-42-00 4 2024-02-05 alcohol use disorder
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 5 2023-11-21 Acute Coronary Syndrome
Impact of CardiolRx on Myocardial Recovery in patients with Acute Myocarditis. Ended

2024-514639-10-00 4 2023-03-30 Acute Myocarditis
Evaluation de l’efficacité des alpha-bloquants (Tamsulosine) dans le traitement de la dysurie symptomatique de la sclérose en plaques chez l … Ended

2024-516880-10-00 4 2022-06-08 Patiente atteinte de sclérose en plaques (score EDSS < 7,5) avec dysur
A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tolerability of the investigational product … Ended

2024-512123-37-00 5 2021-05-27 Parkinson's disease
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 5 2019-05-24 Adults at high risk of cardiovascular events without prior MI or strok

Showing 73–87 of 87 trials